Details of Protein
| General Information of Protein (ID: PRT00156) | |||||
|---|---|---|---|---|---|
| Name | Arylamine N-acetyltransferase 2 (NAT2) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
Arylamide acetylase 2; N-acetyltransferase type 2; NAT-2; Nat2; Aac2
|
||||
| Gene Name | Nat2 | Gene ID | |||
| UniProt ID | |||||
| Family | Transferases (EC 2) | ||||
| EC Number | EC: 2.3.1.5 (Click to Show/Hide the Complete EC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MDIEAYFERIGYQSTRSKLDLKTLTEILQHQIRAIPFENLNIHCGESMELSLEAIFDQIV
RKKRGGWCLQVNHLLYWALTKLGFETTMLGGYVFNTPANKYSSGMIHLLVQVTISGKDYI VDAGFGRSYQMWEPLELTSGKDQPQVPAIFRLTEENGTWYLDQIRREQYVPNQEFINSDL LEKNKYRKIYSFTLEPRTIEDFESMNTYLQTSPASVFTSKSFCSLQTPEGVHCLVGSTLT YRRFSYKDNVDLVEFKSLTEEEIEDVLRTIFGVSLERKLVPKHGDRFFTI |
||||
| Function | Participates in the detoxification of a plethora of hydrazine and arylamine drugs. 2-aminofluorene and p-aminobenzoic acid (PABA) are preferred substrates for NAT-2. Less activity with anisidine and barely detectable with SMZ. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Homogeneous non-metal compounds | ||||||
| Hydrazine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | Hydrazine concentration: increase (FC = 1.28) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of NAT leads to the increase of hydrazine levels compared with control group. | |||||
| Lipids and lipid-like molecules | ||||||
| Omega-3 Fatty Acids | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | Omega-3 Fatty Acids concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of NAT leads to the increase of omega-3 fatty Acids levels compared with control group. | |||||
| Organic acids and derivatives | ||||||
| s-Hexylglutathione | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | s-Hexylglutathione concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of NAT leads to the decrease of s-hexylglutathione levels compared with control group. | |||||
| Organo heterocyclic compounds | ||||||
| INH-vitamin B6 (PL) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | INH-vitamin B6 (PL) concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of NAT leads to the increase of INH-vitamin B6 (PL) levels compared with control group. | |||||
| INH-vitamin B6 (PLP) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | INH-vitamin B6 (PLP) concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of NAT leads to the increase of INH-vitamin B6 (PLP) levels compared with control group. | |||||
| Organoheterocyclic compounds | ||||||
| Acetylhydrazine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | Acetylhydrazine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of NAT leads to the decrease of acetylhydrazine levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | Acetylhydrazine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of NAT leads to the decrease of acetylhydrazine levels compared with control group. | |||||
| Isoniazid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | Isoniazid concentration: increase (FC = 1.86) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual ... | |||||
| Details | It is reported that knockout of NAT leads to the increase of isoniazid levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Nat2 | |||||
| Induced Change | Isoniazid concentration: increase (FC = 2.00) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual ... | |||||
| Details | It is reported that knockout of NAT leads to the increase of isoniazid levels compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver. Biochem Pharmacol. 2017 Dec 1;145:218-225. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

